Skip to main content

ROYAL BANK OF CANADA

Bank

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1000275 TORONTO, A6

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$273,809
+$111,132 QoQ
Shares Held
16,135
+47.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 77% Shared 15% None 7%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Derivatives in AUPH

reported options exposure · as of Jun 30, 2021
CallValue
$2,864,160
CallShares
221,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. AUPH ranks #96 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273,809 16,135
2026-03-31 $162,677 10,977
2025-12-31 $240,731 15,093
2025-09-30 $3,053,333 276,320
2025-06-30 $2,375,985 280,518
2025-03-31 $2,955,993 367,661
2024-12-31 $1,997,887 222,482
2024-09-30 $411,262 56,107
2024-06-30 $241,474 42,290
2024-03-31 $181,025 36,133
2023-12-31 $489,639 54,465
2023-09-30 $456,875 58,800
2023-06-30 $247,827 25,602
2023-03-31 $482,063 43,984
2022-12-31 $136,575 31,615
2022-09-30 $385,346 51,243
2022-06-30 $502,961 50,046
2022-03-31 $400,516 32,352
2021-12-31 $866,429 37,885
2021-09-30 $465,039 21,014
2021-06-30 $2,864,160 221,000
2021-06-30 $1,760,200 135,818
2021-03-31 $3,245,170 249,917
2020-12-31 $1,952,449 141,175
2020-09-30 $288,073 19,557
2020-06-30 $91,649 5,640
2020-03-31 $76,612 5,280